T Kinoshita

ORCID: 0000-0001-9933-0306
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Diabetes Management and Research
  • Advanced Breast Cancer Therapies
  • Pancreatic function and diabetes
  • Molecular Biology Techniques and Applications
  • Hematopoietic Stem Cell Transplantation
  • Diabetes Treatment and Management
  • Diabetes and associated disorders
  • Electrolyte and hormonal disorders
  • Hemoglobinopathies and Related Disorders
  • CNS Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Mobile Health and mHealth Applications
  • Cancer-related Molecular Pathways
  • Cardiac tumors and thrombi
  • Peptidase Inhibition and Analysis
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Xenotransplantation and immune response
  • PI3K/AKT/mTOR signaling in cancer
  • Mesenchymal stem cell research
  • Hormonal Regulation and Hypertension
  • Cutaneous lymphoproliferative disorders research
  • Nutrition and Health in Aging
  • Diabetes Management and Education

Nagoya University
1998-2024

Aichi Cancer Center
2004-2014

Kyoto University
2008

Osaka University
2008

Microbial Chemistry Research Foundation
2008

Higashi Nagoya National Hospital
2004

National Cancer Center Hospital East
2004

Zenyaku Kogyo (Japan)
2004

Sapienza University of Rome
1999

Queen Mary Hospital
1999

Background In recent years, technologies promoting the digitization of self-monitoring blood glucose (SMBG) records including app-cloud cooperation systems have emerged. Studies combining these technological interventions with support from remote health care professionals reported improvements in glycemic control. Objective To assess use an system linked SMBG devices clinical settings, we evaluated its effects on outpatient management diabetes without professional support. Methods this...

10.2196/48019 article EN cc-by JMIR Diabetes 2024-01-19

The prognosis of patients with primary mediastinal large B-cell lymphoma has improved over recent years. However, the optimal treatment strategy including role radiotherapy remains unknown. We retrospectively analyzed clinical outcomes 345 newly diagnosed in Japan. With a median follow up 48 months, overall survival at four years for treated R-CHOP (n=187), CHOP (n=44), DA-EPOCH-R (n=9), 2nd- or 3rd-generation regimens, and chemotherapy followed by autologous stem cell transplantation were...

10.3324/haematol.2014.111203 article EN cc-by-nc Haematologica 2014-09-12

Background Classical Hodgkin's lymphoma is characterized by Hodgkin and Reed Sternberg cells, which are of B-cell origin in many cases. We recently highlighted the adverse prognostic significance cytotoxic molecule expression patients with classical lymphoma. However, clinical characteristics molecule-positive remain controversial.Design Methods investigated clinicopathological profiles 32 lymphoma, comprising 23 nodular sclerosis 9 mixed cellularity, compared these those 55 nodal peripheral...

10.3324/haematol.2011.041079 article EN cc-by-nc Haematologica 2011-08-22

We have previously found that the angiotensin-converting enzyme (ACE) carries GPI-anchored protein releasing activity (GPIase) as well dipeptidase activity. Testicular ACE (tACE), male germinal specific isozyme, plays a crucial role in fertilization. The amino-terminal region of this isozyme is different from somatic (sACE) and contains potential O-linked glycosylation sites. By multiple mutagenesis after an silico prediction, amino acid residues acquiring O-glycans were assigned. Both...

10.1093/jb/mvn148 article EN The Journal of Biochemistry 2008-10-25

Hyponatremia leads to severe central nervous system disorders and requires immediate treatment in some cases. However, a rapid increase serum sodium (s-Na) concentration could cause osmotic demyelination syndrome. To achieve safety hyponatremia treatment, we develop prediction model of s-Na using machine learning. Among the 341 47 patients admitted two tertiary hospitals for (s-Na <130 mEq/L), those who were general unit with urine <20 mEq/L or treated desmopressin excluded. Ultimately, 74...

10.1507/endocrj.ej23-0561 article EN cc-by-nc-nd Endocrine Journal 2024-01-01

AimsIn our previously reported randomized controlled trial in patients with noninsulin-treated type 2 diabetes, the use of flash glucose monitoring (FGM) improved glycated hemoglobin (HbA1c), and improvement was sustained after cessation monitoring. In this post-hoc analysis, we examined data from to identify factors that influenced FGM efficacy.MethodsWe analyzed for 48 49 participants group who completed clarify changes various parameters related HbA1c FGM.ResultsAnalyses during 12-week...

10.1016/j.pcd.2023.09.009 article EN cc-by-nc-nd Primary care diabetes 2023-10-09

Objective: Resting energy expenditure (REE) decreases if there is reduced intake and body weight (BW). The decrease in REE could make it difficult for patients with obesity to maintain decreased BW. This study aimed investigate the correlation among changes REE, intake, BW during loss process obesity. Materials methods: We conducted a retrospective cohort of hospitalized treatment Japan. Patients received fully controlled [...]

10.20945/2359-3997000000532 article EN cc-by Archives of Endocrinology and Metabolism 2022-12-05

<sec> <title>BACKGROUND</title> In recent years, technologies promoting the digitization of self-monitoring blood glucose (SMBG) records including app-cloud cooperation systems have emerged. Studies combining these technological interventions with support from remote health care professionals reported improvements in glycemic control. </sec> <title>OBJECTIVE</title> To assess use an system linked SMBG devices clinical settings, we evaluated its effects on outpatient management diabetes...

10.2196/preprints.48019 preprint EN 2023-04-20

6704 Background: Optimal combination schedule of R-CHOP for untreated FL is still uncertain. Quantitative evaluation MRD may suggest a correlation between the treatment and its outcome. Methods: We conducted randomized phase II study comparing 6 cycles (concurrent; Arm C) CHOP followed by weekly doses rituximab (sequential; S) previously untreated, advanced-stage indolent B-cell lymphoma, mainly consisting FL. DNA bone marrow (BM) peripheral blood (PB) were obtained before (baseline), after...

10.1200/jco.2004.22.14_suppl.6704 article EN Journal of Clinical Oncology 2004-07-15
Coming Soon ...